Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for ENTG and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for ENTG and 80,000+ other tickers.
See exactly how ENTG's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ENTG and 80,000+ other tickers.
Entegris, Inc. is a global enterprise that develops, manufactures, and supplies critical solutions for microcontamination control, specialty chemicals, and advanced material handling. The company operates extensively across North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. Its operations are structured into three primary segments: Specialty Chemicals and Engineered Materials (SCEM): This division delivers high-performance, ultra-pure process chemistries, specialized gases, and advanced materials, along with their associated delivery systems, crucial for…
Entegris (ENTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
On October 21, 2026, Entegris Inc (ENTG) shares rose 3.4% today, closing at $147.69. Over the past 52 weeks, the stock has traded between $67.97 and $186.94, hi
Louisbourg Investments Inc. lifted its stake in Entegris, Inc. (NASDAQ: ENTG) by 99.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,397 shares of the semiconductor company's stock after purchasing an additional 10,194 shares during the period. Louisbourg Investments
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Savillex, LLC ("Savillex"), a leading provider of high-purity fluid handling solutions for life science and laboratory applications worldwide, today announced that it has completed its acquisition of Entegris, Inc.'s Life Sciences Fluid Management business. The acquired portfolio includes bioprocessing and pharmaceutical manufacturing solutions, including Aramus™ and PE bags, single-use assemblies, and components used across discovery, clinical, and commerc.
